Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).

Authors:
Riddell MC; Li Z; Gal RL; Calhoun P; Jacobs PG and 9 more

Journal:
Diabetes Care

Publication Year: 2023

DOI:
10.2337/dc22-1721

PMCID:
PMC10090894

PMID:
36795053

Journal Information

Full Title: Diabetes Care

Abbreviation: Diabetes Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Duality of Interest. M.C.R. reports consulting fees from the Jaeb Center for Health Research, Eli Lilly, Zealand Pharma, and Zucara Therapeutics; speaker fees from Sanofi Diabetes, Eli Lilly, Dexcom Canada, and Novo Nordisk; and stock options from Supersapiens and Zucara Therapeutics. P.G.J. reports grants from the National Institutes of Health, The Leona M. and Harry B. Charitable Trust, the Juvenile Diabetes Research Foundation, Dexcom, and the Oregon Health & Science University Foundation; consultancy fees from the Clinical Data Interchange Standards Consortium; U.S. patents 62/352939, 63/269094, 62/944287, 8810388, 9480418, 8317700, 61/570382, 8810388, 7976466, and 6558321; and stock options from Pacific Diabetes Technologies, outside the submitted work. M.A.C. is chief medical officer of Glooko, Inc., and reports grants or contracts from Dexcom, Abbott Diabetes Care, the National Institutes of Health, the Juvenile Diabetes Research Foundation, the Emily Rosebud Foundation, Eli Lilly, Tolerion, and Garmin. S.R.P. reports grants from The Leona M. and Harry B. Helmsley Charitable Trust, the National Institutes of Health, and the Jaeb Center for Health Research and an honorarium from the American Diabetes Association, outside the submitted work. J.R.C. reports grants from the Juvenile Diabetes Research Foundation, the National Institutes of Health, Dexcom, and Medtronic and consultancy fees from Novo Nordisk, Insulet, and Zealand Pharma, outside the submitted work. R.W.B. reports consulting fees, paid to institution, from Insulet, Bigfoot Biomedical, vTv Therapeutics, and Eli Lilly; grant support and supplies, provided to institution, from Tandem and Dexcom; and supplies from Ascenia and Roche. M.R.R. reports consultancy fees from Zealand Pharma."

Evidence found in paper:

"Funding. Research reported in this publication was supported by The Leona M. and Harry B. Helmsley Charitable Trust. Pennington Biomedical Research Center (institution of C.K.M.) is supported by Nutrition Obesity Research Centers grant P30 DK072476 entitled “Nutrition and Metabolic Health Through the Lifespan” sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases and by grant U54 GM104940 from the National Institute of General Medical Sciences, which funds the Louisiana Clinical and Translational Science Center. Verily (South San Francisco, CA) provided the Study Watch at no cost. Dexcom provided continuous glucose monitors at a discounted rate."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025